Varicella zoster virus vaccine

Details for Australian Patent Application No. 2006222225 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Hanon, Emmanuel Jules; Stephenne, Jean

Agent Shelston IP

Pub. Number AU-B-2006222225

PCT Pub. Number WO2006/094756

Priority 0504436.7 03.03.05 GB

Filing date 1 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 16 August 2012

International Classifications

C07K 14/04 Peptides having more than 20 amino acids

A61K 39/25 Medicinal preparations containing antigens or antibodies

A61K 39/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/22 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 7/04 Viruses, e.g. bacteriophages - Inactivation or attenuation

A61K 39/00 Medicinal preparations containing antigens or antibodies

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094756 Priority application(s): WO2006/094756

16 August 2012 Application Accepted

  Published as AU-B-2006222225

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222232-3,4,5-substituted pipeidine compounds

2006222213-Device for administering a breathing gas and method for adjusting breathing gas pressures that alternate at least in some phases